Mechanisms for rescue of correctable folding defects in CFTRΔF508

Molecular Biology of the Cell

Volumn 20, Issue 18, 2009, Pages 4059-4069

  Grove, Diane E ^a   Rosser, Meredith F N ^a   Hong, Yu Ren ^a   Naren, Anjaparavanda P ^b   Cyr, Douglas M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CORR 4A; THIAZOLE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN LIGASE CHIP1; UBIQUITIN LIGASE RMA1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; UBIQUITINATION;

CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; SUPPRESSION, GENETIC; THIAZOLES;

EID: 70350236409     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-09-0929     Document Type: Article

References (51)

1. Alonso, M. J., Heine-Suner, D., Calvo, M., Rosell, J., Gimenez, J., Ramos, M. D., Telleria, J. J., Palacio, A., Estivill, X., and Casals, T. (2007). Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry. Ann. Hum. Genet. 71, 194-201.
2. Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., and Welsh, M. J. (1991). Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253, 202-205. (Pubitemid 21917143)
3. Bobadilla, J. L., Macek, M., Jr., Fine, J. P., and Farrell, P. M. (2002). Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum. Mutat. 19, 575-606.
4. Brown, C. R., Hong-Brown, L. Q., Biwersi, J., Verkman, A. S., and Welch, W. J. (1996). Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1, 117-125. (Pubitemid 126670773)
5. Burger, A. M., and Seth, A. K. (2004). The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur. J. Cancer 40, 2217-2229.
6. Chen, E. Y., Bartlett, M. C., Loo, T. W., and Clarke, D. M. (2004). The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 279, 39620-39627.
7. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., and Smith, A. E. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834. (Pubitemid 120035055)
8. Choi, M. Y., Cardarelli, L., Therien, A. G., and Deber, C. M. (2004). Non-native interhelical hydrogen bonds in the cystic fibrosis transmembrane conductance regulator domain modulated by polar mutations. Biochemistry 43, 8077-8083. (Pubitemid 38808262)
9. Cui, L., Aleksandrov, L., Chang, X. B., Hou, Y. X., He, L., Hegedus, T., Gentzsch, M., Aleksandrov, A., Balch, W. E., and Riordan, J. R. (2007). Domain interdependence in the biosynthetic assembly of CFTR. J. Mol. Biol. 365, 981-994.
10. Cyr, D. M., Hohfeld, J., and Patterson, C. (2002). Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem. Sci. 27, 368-375.
11. Dai, Q., Zhang, C., Wu, Y., McDonough, H., Whaley, R. A., Godfrey, V., Li, H. H., Madamanchi, N., Xu, W., Neckers, L., Cyr, D., and Patterson, C. (2003). CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J. 22, 5446-5458. (Pubitemid 37279954)
12. Dalal, S., Rosser, M. F., Cyr, D. M., and Hanson, P. I. (2004). Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol. Biol. Cell 15, 637-648.
13. Dawson, R. J., and Locher, K. P. (2006). Structure of a bacterial multidrug ABC transporter. Nature 443, 180-185.
14. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
15. Du, K., and Lukacs, G. L. (2009). Cooperative assembly and misfolding of CFTR domains in vivo. Mol. Biol. Cell 20, 1903-1915.
16. Du, K., Sharma, M., and Lukacs, G. L. (2005). The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat. Struct. Mol. Biol. 12, 17-25.
17. Gregory, R. J., Rich, D. P., Cheng, S. H., Souza, D. W., Paul, S., Manavalan, P., Anderson, M. P., Welsh, M. J., and Smith, A. E. (1991). Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11, 3886-3893.
18. He, L., Aleksandrov, A. A., Serohijos, A. W., Hegedus, T., Aleksandrov, L. A., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008). Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J. Biol. Chem. 283, 26383-26390.
19. Hyde, S. C., et al. (1990). Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346, 362-365. (Pubitemid 20226039)
20. Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., and Riordan, J. R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135.
21. Kleizen, B., van Vlijmen, T., de Jonge, H. R., and Braakman, I. (2005). Folding of CFTR is predominantly cotranslational. Mol. Cell 20, 277-287.
22. Lee, M. J., Pal, K., Tasaki, T., Roy, S., Jiang, Y., An, J. Y., Banerjee, R., and Kwon, Y. T. (2008). Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway. Proc. Natl. Acad. Sci. USA 105, 100-105.
23. Lewis, H. A., et al. (2004). Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 23, 282-293. (Pubitemid 38294493)
24. Li, M., McCann, J. D., Liedtke, C. M., Nairn, A. C., Greengard, P., and Welsh, M. J. (1988). Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium. Nature 331, 358-360. (Pubitemid 18042494)
25. Loo, T. W., Bartlett, M. C., and Clarke, D. M. (2008). Correctors promote folding of the CFTR in the endoplasmic reticulum. Biochem. J. 413, 29-36.
26. Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., and Cyr, D. M. (1999). The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18, 1492-1505. (Pubitemid 29127063)
27. Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M., and Cyr, D. M. (2001). The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3, 100-105.
28. Mendoza, J. L., and Thomas, P. J. (2007). Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J. Bioenerg. Biomembr. 39, 499-505.
29. Morito, D., Hirao, K., Oda, Y., Hosokawa, N., Tokunaga, F., Cyr, D. M., Tanaka, K., Iwai, K., and Nagata, A. K. (2008). Gp78 Cooperates with RMA1 in Endoplasmic Reticulum-associated Degradation of CFTRΔF508. Mol. Biol. Cell 19, 1328-1336.
30. Mornon, J. P., Lehn, P., and Callebaut, I. (2008). Atomic model of human cystic fibrosis transmembrane conductance regulator: Membrane-spanning domains and coupling interfaces. Cell Mol. Life Sci. 65, 2594-2612.
31. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J., and Verkman, A. S. (2005). Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115, 2564-2571.
32. Riordan, J. R., et al. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073. (Pubitemid 19231814)
33. Rosser, M. F., Grove, D. E., Chen, L., and Cyr, D. M. (2008). Assembly and misassembly of CFTR: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of MSD1 and MSD2. Mol. Biol. Cell 19, 4570-4579.
34. Rowe, S. M., Miller, S., and Sorscher, E. J. (2005). Cystic fibrosis. N. Engl. J. Med. 352, 1992-2001.
35. Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., and Kopito, R. R. (1996). Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271, 635-638.
36. Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008). Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc. Natl. Acad. Sci. USA 105, 3256-3261.
37. Therien, A. G., Grant, F. E., and Deber, C. M. (2001). Interhelical hydrogen bonds in the CFTR membrane domain. Nat. Struct. Biol. 8, 597-601.
38. Thibodeau, P. H., Brautigam, C. A., Machius, M., and Thomas, P. J. (2005). Side chain and backbone contributions of Phe508 to CFTR folding. Nat. Struct. Mol. Biol. 12, 10-16.
39. Van Goor, F., et al. (2006). Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L1117-L1130.
40. Vankeerberghen, A., Wei, L., Teng, H., Jaspers, M., Cassiman, J. J., Nilius, B., and Cuppens, H. (1998). Characterization of mutations located in exon 18 of the CFTR gene. FEBS Lett. 437, 1-4. (Pubitemid 28498229)
41. Varga, K., Goldstein, R. F., Jurkuvenaite, A., Chen, L., Matalon, S., Sorscher, E. J., Bebok, Z., and Collawn, J. F. (2008). Enhanced cell-surface stability of rescued DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones. Biochem. J. 410, 555-564.
42. Wang, X., et al. (2006a). Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803-815. (Pubitemid 44716255)
43. Wang, Y., Bartlett, M. C., Loo, T. W., and Clarke, D. M. (2006b). Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones. Mol. Pharmacol. 70, 297-302.
44. Wang, Y., Loo, T. W., Bartlett, M. C., and Clarke, D. M. (2007). Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein. J. Biol. Chem. 282, 33247-33251.
45. Ward, C. L., and Kopito, R. R. (1994). Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269, 25710-25718.
46. Ward, C. L., Omura, S., and Kopito, R. R. (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127.
47. Wilhovsky, S., Gardner, R., and Hampton, R. (2000). HRD gene dependence of endoplasmic reticulum-associated degradation. Mol. Biol. Cell 11, 1697-1708.
48. Xiong, X., Bragin, A., Widdicombe, J. H., Cohn, J., and Skach, W. R. (1997). Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. J. Clin. Invest. 100, 1079-1088.
49. Younger, J. M., Chen, L., Ren, H. Y., Rosser, M. F., Turnbull, E. L., Fan, C. Y., Patterson, C., and Cyr, D. M. (2006). Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126, 571-582. (Pubitemid 44163603)
50. Younger, J. M., Ren, H. Y., Chen, L., Fan, C. Y., Fields, A., Patterson, C., and Cyr, D. M. (2004). A foldable CFTRΔF508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J. Cell Biol. 167, 1075-1085. (Pubitemid 40066623)
51. Zhang, F., Kartner, N., and Lukacs, G. L. (1998). Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5, 180-183.